St. Vincent's Comprehensive Cancer Center — New York, New York

St. Vincent's Comprehensive Cancer Center is a clinical research site located in New York, New York, United States 10011.

Crixeo Health Trust Score: 84/100 (GOOD). This profile has not yet been claimed by the site owner.

St. Vincent's Comprehensive Cancer Center has participated in 22 clinical trials.

Therapeutic areas: Ovarian Cancer, AML, Acute Myeloid Leukemia.

Sponsors: Unither Pharmaceuticals, Gemin X, Seagen Inc..

Sponsor Feasibility Report

Trust Score: 84/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for St. Vincent's Comprehensive Cancer Center?

St. Vincent's Comprehensive Cancer Center has a Crixeo Trust Score of 84/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has St. Vincent's Comprehensive Cancer Center conducted?

St. Vincent's Comprehensive Cancer Center has 22 clinical trials on record. Their work covers Ovarian Cancer, AML, Acute Myeloid Leukemia.

Is St. Vincent's Comprehensive Cancer Center accredited by Crixeo Health?

Yes — St. Vincent's Comprehensive Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about St. Vincent's Comprehensive Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.